PO.CL01.08 · 临床研究
Liquid Biopsies: Circulating Nucleic Acids 2
-
2582 · PDF 通过整合基于 CRISPR 的细胞外囊泡 RNA 和蛋白质分析推进液体活检 Advancing liquid biopsies via integrated CRISPR-based extracellular vesicle RNA and protein analyses Cesar M. Castro, Jayeon Song, Hakho Lee
-
2583 · PDF 肿瘤知情的循环肿瘤 DNA 动态反映肾细胞癌的侵袭性组织学和影像学疾病状态 Tumor-informed circulating tumor DNA dynamics reflect aggressive histology and radiologic disease status in renal cell carcinoma Eric Martin, Eun-mi Yu, Annika Murthi, Hongkun Wang, Laura Linville, Jeanny B. Aragon-Ching
-
2584 · PDF 来自液体活检的甲基化特征可预测结直肠癌患者对抗 EGFR 治疗的反应 Methylation signatures from liquid biopsies predict anti-EGFR therapy response in patients with colorectal cancer Xuwen Li, Mingyang Cai, Shile Zhang, Nicole Zhang, Reagan Barnett, Tingting Jiang, Kota Ouchi, Yoshiaki Nakamura, Kimberly Banks, Justin Odegaard, Darya Chudova
-
2585 · PDF 转移性去势抵抗性前列腺癌(mCRPC)中的血浆游离 DNA 核小体足迹 Plasma cell-free DNA nucleosome footprints in metastatic castration-resistant prostate cancer (mCRPC) Denisa Bogdan, Jan Rekowski, George Seed, Claudia Bertan, Jane Goodall, Gemma Fowler, Penelope Flohr, Christine Geffriaud-Ricouard, Mustapha Chadjaa, Sandrine Mace, Isaac Lazzeri, Ellen Heitzer, Suzanne Carreira, Wei Yuan, Johann S. de Bono
-
2586 · PDF 研究液体活检中的肾母细胞瘤 DNA 甲基化特征 Investigating a Wilms tumor DNA methylation signature in liquid biopsies Mariusz Shrestha, Arteen Torabi-Marashi, Marina Dutra, Sanaa Choufani, Trevor J. Pugh, Rosanna Weksberg, Jack Brzezinski
- 2587 2587 用于检测血浆中游离转移性前列腺癌DNA的甲基化基因panel的开发 Development of a methylated gene panel for detection of cell-free, metastatic prostate cancer DNA in plasma Gang Yu, Mary Jo Fackler, Liqun Zhang, Wenfei Xia, Roshni Saravanan, Ezra Baraban, Eunice Van Den Berg, Adam Botha, Pamela Michelow, Reubina Wadee, Maureen Joffe, Wenlong Carl Chen, Thomas Pisanic, Michelle Petri, Jun Luo, Channing Paller, Samuel Denmeade, Leslie Cope, Saraswati Sukumar
-
2588 · PDF 用肿瘤指导的MRD检测监测ESR1及其他与耐药相关的突变:分析验证与真实世界数据 Monitoring ESR1 and other mutations linked to resistance with a tumor-informed MRD test: Analytical validation and real world data Jason Harris, John M. Lyle, Gabor Bartha, Sean M. Boyle, Josette Northcott, Devayani Bhave, Claudia Aliguillen, Shuyuan Ma, Rachel M. Pyke, Steven Dea, Dan Norton, Erin Ayash, Richard O. Chen
-
2589 · PDF OvaPrint与多组学分析用于附件肿块精确分类的前瞻性验证 Prospective verification of OvaPrint and multi-omic profiling for precise adnexal mass classification Thomas Simon, Lynda D. Roman, X. Mona Guo, Ben Yi Tew, Gerald C. Gooden, Monica Neuman, Emma Barber, Elisa Romeo, Todd Holscher, Renee Wunderley, Danielle Goldberg, Krishna Morampudi, Dalia Daujotyte, Monique Spillman, Bodour Salhia
-
2590 · PDF 尿液cfDNA 4-mer末端基序特征在泌尿生殖系统癌症的组织起源分类中优于其他片段组学特征 Urine cfDNA 4-mer end-motif signatures outperform other fragmentomic features for tissue-of-origin classification in genitourinary cancers Jessica Linford, Pradeep S. Chauhan, Irfan Alahi, Yohan Kim, Arpit Panda, Nathan Colon, Ryan Mueller, Faridi Qaium, Eric H. Kim, Melissa A. Reimers, Zachary L. Smith, Woodson W. Smelser, Fabrice Lucien-Matteoni, Aadel A. Chaudhuri
-
2591 · PDF 癌症患者循环中的序列和结构DNA改变 Sequence and structural DNA alterations in the circulation of patients with cancer Daniel C. Bruhm, Carolyn Hruban, Adrianna L. Bartolomucci, Akshaya V. Annapragada, Sarah Short, Shashikant Koul, Kaui P. Lebarbenchon, Julia S. Johansen, Inna M. Chen, Andrei Sorop, Razvan Iacob, Speranta Iacob, Liana Gheorghe, Simona Dima, Katherine A. McGlynn, Manuel Ramírez-Zea, John Groopman, PLCRC-MEDOCC group, Remond J. A. Fijneman, Gerrit A. Meijer, Zachariah H. Foda, Jillian Phallen, Robert B. Scharpf, Victor E. Velculescu
-
2592 · PDF 一部分转移性结直肠癌患者中循环肿瘤DNA的夜间升高 Nocturnal rise in circulating tumor DNA in a subset of metastatic colorectal cancer patients Ekaterina S. Kuligina, Aleksandr S. Martianov, Liliya S. Baboshkina, Arina S. Perevalova, Yana V. Belysheva, Anastasia N. Ershova, Tatiana A. Laidus, Aram A. Musaelyan, Ekaterina M. Anokhina, Gulfiia M. Teletaeva, Aglaya G. Iyevleva, Evgeny N. Imyanitov
-
2593 · PDF Enspyre MRD:一种低测序深度下的超灵敏试剂盒式MRD解决方案的验证 Enspyre MRD: Validation of an ultra-sensitive kitted MRD solution at low sequencing depth Magdalena Stolarek-Januszkiewicz, Sophie Hackinger, Sarah Diels, Katarzyna Anton, Amy Lovell, Ernesto Lowy-Gallego, Ana-Luisa Silva, Maria Litovchenko, Bart Tegenbos, Emmanuel Rivière, Dirk Goossens, Nathalie Bernard, Justyna Mordaka, Iyelola Turner, Lisa Van den Bossche, Lien Heyrman, Jan Van de Velde, Pieter Mestdagh, Jurgen Del Favero, Barnaby Balmforth
-
2594 · PDF 一种用于稀有分子检测的深度采样和单分子数字计数检测方法 A deep sampling and single molecule digital counting assay for rare molecule detection Danny Overman, Cindy Wang, Jung won Keum, Jesse Soliman, Emily Blair, Eleen Shum, Tricia Zwiefelhofer
- 2595 2595 一种用于超灵敏分子残留病灶检测(MRD)的新型双链全基因组测序(WGS)方法 A novel dual-strand whole-genome sequencing (WGS) method for ultra-sensitive molecular residual disease detection (MRD) Andrew Slatter, Jessica Moore, Esther Musgrave-Brown, Dhamayanthi Pugazhendhi, Trevor Ho, Alex Calderwood, Dale Weekes, Seong Won Cha, Christopher Edlund, Sven Bilke, Huihong You, Chris Truong, Jeff Tsai, Khai Luong, Li Liu, Yunjiao Zhu, Jeff Fisher, Traci Pawlowski, James Han, Fiona Kaper, Cande Rogert
-
2596 · PDF 用于结直肠癌基因组-表观基因组整合ctDNA检测的超灵敏多重ddPCR Ultrasensitive multiplex ddPCR for integrated genomic-epigenomic ctDNA detection in colorectal cancer Ya Zhou, Yuwei Ni, Xingyu Yang, Qiancheng You, Jing Su, Yunpeng Zhang, Xiaoling Li, Xinyue Kang, Jiayue Xu, Zhihong Zhang, Bingsi Li
- 2597 2597 基线cfDNA片段组学可识别有早期进展风险的多发性骨髓瘤患者 Baseline cfDNA fragmentomics identifies multiple myeloma patients at risk of early progression Dor David Abelman, Jenna Eagles, Aimee Wong, Saumil Shah, Jeffrey Bruce, Stephanie Pedersen, David S. Scott, Cecilia Bonolo de Campos, Signy Chow, Darrell White, Irwindeed Sandhu, Kevin Song, Esteban Braggio, Shaji Kunnathu Kumar, Alli Murugesan, Tony Reiman, A. Keith Stewart, Suzanne Trudel, Trevor J. Pugh
-
2598 · PDF 一种超高灵敏度肿瘤指导MRD检测的分析验证 Analytical validation of an ultra-high sensitivity tumor-informed MRD assay Ashley Acevedo, Kelly Colbert, Kyle Trettin, Alexander Ham, Genevieve Gould
-
2599 · PDF 基于甲基化的循环肿瘤DNA可预测根治性治疗后非小细胞肺癌(NSCLC)的复发 Methylation-based circulating tumor DNA predicts recurrence in definitively treated non-small cell lung cancer (NSCLC) Jisoo Lee, Eun Ji Song, Youngjun Lee, Jongsu Kim, Yuchan Kim, Anthony Wong, Sanghwa Kim, Liam I. Chung, Young Kwang Chae
-
2600 · PDF 通过对血浆核小体进行表观遗传学分析研究非小细胞肺癌患者的治疗反应与耐药 Investigating treatment response and resistance in non-small cell lung cancer patients through epigenetic profiling of plasma nucleosomes Christoffer T. Maansson, Simone Stensgaard, Emma Pedersen, Anders Lade Nielsen, Peter Meldgaard, Boe Sandahl Sorensen
-
2601 · PDF 血浆循环游离RNA中的生物标志物尾部基因可实现前列腺癌的准确检测 Biomarker tail genes in blood plasma cell-free RNA enable accurate detection of prostate cancer Annelien Morlion, Philippe Decruyenaere, Kathleen Schoofs, Jasper Anckaert, Nickolas J. Ramirez, Justine Nuytens, Eveline Vanden Eynde, Kimberly Verniers, Celine Everaert, Guy Brusselle, Steven Callens, Filomeen Haerynck, Dimitri Hemelsoet, Eric Hoste, Jo Lambert, Nicolaas Lumen, Fritz Offner, Koen Paemeleire, Vanessa Smith, Lies Van den Eynde, Jo Van Dorpe, Amber Vanhaecke, Hans Van Vlierberghe, An Mariman, Olivier Thas, Jo Vandesompele, Pieter Mestdagh
-
2602 · PDF 靶向治疗在通过液体活检被归类为TMB-高的癌症中的影响:来自Gustave Roussy分子肿瘤委员会的见解 Impact of targeted therapies in cancers classified as TMB-high by liquid biopsy: Insights from the Gustave Roussy molecular tumor board Adrien Mouren, Berenger POIRIER, Antoine Italiano, Matthieu Roulleaux Dugage, Yohann Loriot, Antoine Hollebecque, Anas Gazzah, Barbara Pistilli, Christophe Massard, Cyril ROUSSEL-SIMONIN
-
2603 · PDF 跨15种癌症类型和7种亚型的甲基化特征比较 Comparing methylation signatures across 15 cancer types and 7 subtypes Harry Mickalide, Joel Rodriguez-Medina, Fernando L. Mendez, Murat Can Cobanoglu, Scott Dashner, Yuqian Jiang, Kevin Chan, Joshua N. Burton, Trupti Kawli, Johannes G. Reiter, Matthew Rabinowitz, Alexey Aleshin
-
2604 · PDF 术后淋巴渗出液作为肌层浸润性膀胱癌的近端液体活检来源 Postoperative lymphatic exudate as a proximal liquid biopsy source in muscle-invasive bladder cancer Zhuosheng Gu, Zachary Costliow, Seka Lazare, Abbey Crittenden, Adam Harmon, Megan Rivera, Ashley Tellis, Samuel Espinoza, Adam Benson, Marra Francis, Ankeet Shah, Michael R. Abern, Gautum Agarwal, Wendy Winckler
-
2605 · PDF 血浆全外显子组测序(pWES)与组织全外显子组测序(tWES)的一致性评估:非小细胞肺癌(NSCLC)的一项初步研究 Concordance evaluation of plasma whole-exome sequencing (pWES) and tissue whole-exome sequencing (tWES): A pilot study in non-small cell lung cancer (NSCLC) Bingjie Dong, Zhijiao Wang, Carol E. Peña, Xiaoqiao Liu, Gefei Zeng
-
2606 · PDF 一种雌激素受体活性的液体活检检测可预测ER+/HER2−晚期乳腺癌对giredestrant的反应 A liquid biopsy assay of estrogen receptor activity predicts response to giredestrant in ER+/HER2− advanced breast cancer Ann E. Collier, Jon Beagan, Travis Clark, Kristian Cibulskis, Corrie Painter, Mary McGillicuddy, Aparna Gorthi, Khoi Nguyen, James Sullivan, Richard Schwab, Jing Zhu, Pablo Perez-Moreno, Tharu M. Fernando, Matthew Eaton, Carl J. Barrett